Drug intelligence / Profile preview

glucosamine + diacerein

Development stage
Unknown
Lead developer
Captab Biotec
Modality
Small Molecules
Administration
Oral
01

Overview

ELCOS-D is an oral fixed-dose combination of glucosamine sulfate (750 mg) and diacerein (50 mg) developed by Captab Biotec for the treatment of osteoarthritis and joint pain. Glucosamine sulfate is an amino sugar that serves as a precursor for glycosaminoglycan and proteoglycan synthesis, supporting cartilage repair and joint lubrication. Diacerein is an anthraquinone derivative that acts as a slow-acting inhibitor of interleukin-1 beta (IL-1β) signaling, reducing inflammation and cartilage degradation. Together, these components work synergistically to alleviate joint pain, reduce swelling, and improve mobility in patients with osteoarthritis.

Brand names
ELCOS-D
Other names
glucosamine sulfate + diacereinglucosamine sulphate + diacereinglucosamine sulphate potassium chloride + diacerein
02

Targets

IL1R1 (Interleukin-1 Receptor Type 1)IL1B (Interleukin-1 beta)NF-κB

Beyond the preview

Go deeper on glucosamine + diacerein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glucosamine + diacerein.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call